Eucrates Biomedical Acquisition OverviewEucrates Biomedical Acquisition Selling, General & Admin
Selling, General & Admin expenses for EUCR.
Quarterly SG&A Expenses
$268514.00
↓ 47.31% YoY
As of Dec 31, 2022
Annual SG&A Expenses (TTM)
$537028.00
↓ 47.31% YoY
Trailing 12 months ending Dec 31, 2022